We next compare the effect of the novel ER inhibitor AZD9496 and fulvestrant (the classic ER inhibitor) on the growth of pituitary adenoma cells and primary gonadotroph adenoma cells. This evidence concerns the gene ESR1 and functioning gonadotropic adenoma.